ロード中...
Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia
AIM: This post hoc analysis of a double‐blind (DB), randomized, placebo‐controlled, relapse‐prevention study evaluated the effects of paliperidone palmitate once‐every‐3‐months (PP3M) in a subpopulation of adults with early illness schizophrenia (duration ≤5 years) from a clinical trial. METHODS: Pa...
保存先:
| 出版年: | Early Interv Psychiatry |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley Publishing Asia Pty Ltd
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6585630/ https://ncbi.nlm.nih.gov/pubmed/29968279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/eip.12685 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|